Back

Cardiovascular and inflammatory proteomic signatures distinguish mandibular advancement device from CPAP therapy and predict blood pressure response in obstructive sleep apnea

29 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Sleep apnoea and the heart Sleep Apnoea ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yi Hui Ou

Beth Israel Deaconess Medical Center, Boston (United States of America)

6 More presentations in this session

Presentation thumbnail
Dynamic prediction of obstructive sleep apnea progression: a deep learning approach using time-varying smartwatch data
Professor Y. Guo (Beijing, CN)
Abstract Slides
Presentation thumbnail
Independent and combined effects of DASH diet and sleep quality on hypertension
Doctor S. Zhang (Beijing, CN)
Abstract Slides
Presentation thumbnail
The association between obstructive sleep apnea of varying severity and cardiovascular risk: a systematic review and meta-analysis
Doctor C. Niu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Phenogroup-based stratification of cardiovascular risk in obstructive sleep apnea
Doctor Y. Ou (Boston, US)
Abstract Slides
Presentation thumbnail
Sleep–wake circadian organisation (relative amplitude) and incident cardiovascular disease in UK Biobank
Miss H. Wang (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Sleep apnoea and the heart

The Event

Event poster

ESC Congress 2026

29 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of continuous positive airway pressure therapy in patients with paroxysmal atrial fibrillation and obstructive sleep apnea: A randomized controlled trial
31 August 2020
thumbnail
Congress Presentation
A proteomic atlas of atherosclerosis: regional proteomic signatures for plaque inflammation and calcification
30 April 2022
thumbnail
Congress Presentation
Measuring cardiorespiratory fitness in a blood sample. Higher NT-pro-BNP and HS-CRP levels correlate with reduced VO2-peak but not 6-minute walk distance.
13 June 2025
thumbnail
Congress Presentation
Targeting the HIF-1/ASC pathway with dapagliflozin protects against sleep apnea-exacerbated myocardial damage in heart failure
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources